growth hormone-releasing hormone

(redirected from Growth hormone releasing hormone)
Also found in: Dictionary, Thesaurus, Wikipedia.
Related to Growth hormone releasing hormone: somatostatin, Gonadotropin releasing hormone

so·ma·to·lib·er·in

(sō'mă-tō-lib'ĕr-in),
A decapeptide released by the hypothalamus, which induces the release of human growth hormone (somatotropin). Compare: growth hormone-releasing hormone, luteinizing hormone/follicle-stimulating hormone-releasing hormone.
[somatotropin + L. libero, to free, + -in]

growth hormone-releasing hormone (GH-RH)

a neuropeptide released by the hypothalamus that travels to the anterior pituitary to stimulate growth hormone release. Also called somatocrinin, somatoliberin, somatotropin-releasing hormone.

so·ma·to·lib·er·in

(sō'mă-tō-lib'ĕr-in)
A decapeptide released by the hypothalamus, which induces the release of human growth hormone (somatotropin).
Compare: bioregulator
Synonym(s): growth hormone-releasing factor, growth hormone-releasing hormone, somatotropin-releasing factor, somatotropin-releasing hormone.
[somato- + L. libero, to free, + -in]

growth hormone-releasing hormone

Abbreviation: GH-RH
A hormone from the hypothalamus that stimulates the release of growth hormone.
Synonym: somatotropin-releasing hormone
See also: hormone
References in periodicals archive ?
It has been shown that growth hormone response to ghrelin in vivo requires an intact endogenous growth hormone releasing hormone system11.
1), (2) These central nervous system (CNS) controls result in the elaboration of growth hormone releasing hormones (GHRH), which act on the anterior pituitary to release GH.
Doug Kern, VP, Business Development of VGX Animal Health, stated, "This is the first time a single dose of a plasmid-based growth hormone releasing hormone therapy has been directly compared to daily injections of growth hormone.
VGX Pharmaceuticals plans to file three additional INDs for its SynCon[TM] DNA vaccine candidates during the first two quarters of 2008: VGX-3100, a therapeutic vaccine for the treatment for cervical cancer; VGX-3200, a therapeutic based on human growth hormone releasing hormone (GHRH) for cancer-related cachexia (wasting or heavy weight loss); and VGX-3400, a pandemic avian flu vaccine.
VGX is currently developing a portfolio of DNA based vaccines covering HIV, HPV and influenza as well as DNA therapies for cancer-related cachexia based on growth hormone releasing hormone (GHRH).
The candidates include vaccines for human papilloma virus for the treatment of cervical cancer (VGX-3100) and avian influenza (VGX-3400), and a therapeutic based on human growth hormone releasing hormone (VGX-3200) for cancer related cachexia.
VGX is currently developing a portfolio of DNA based vaccines covering HIV, HPV and influenza as well as DNA therapies for cancer and HIV related cachexia based on growth hormone releasing hormone (GHRH).
The patent entitled, "Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone (GHRH)" is part of a broad patent estate covering GHRH sequences and applications.
Under the terms of the agreement, VGX will purchase all significant assets covering ADViSYS' intellectual property including plasmid expression vectors, growth hormone releasing hormone and electrokinetic delivery technology.
Serono has developed and markets the most comprehensive line of products to treat pediatric growth hormone deficiency, including growth hormone and growth hormone releasing hormone.

Full browser ?